UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 33

Sortiert nach

Human positron emission tomography studies of brain neurokinin 1 receptor occupancy by aprepitant

Biological psychiatry (1969), 2004-05, Vol.55 (10), p.1007-1012

2004

Volltextzugriff (PDF)

Evaluation of Potential Inductive Effects of Aprepitant on Cytochrome P450 3A4 and 2C9 Activity

Journal of clinical pharmacology, 2004-03, Vol.44 (3), p.215-223

2004

Volltextzugriff (PDF)

Pharmacokinetics of Aprepitant After Single and Multiple Oral Doses in Healthy Volunteers

Journal of clinical pharmacology, 2006-03, Vol.46 (3), p.291-300

2006

Volltextzugriff (PDF)

Assay methodology for the quantitation of unbound ertapenem, a new carbapenem antibiotic, in human plasma

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2003-01, Vol.783 (1), p.1-9

2003

Volltextzugriff (PDF)

Pharmacokinetics and pharmacodynamics of ertapenem: an overview for clinicians

Journal of antimicrobial chemotherapy, 2004-06, Vol.53 (suppl-2), p.ii23-ii28

2004

Volltextzugriff (PDF)

Effects of the neurokinin1 receptor antagonist aprepitant on the pharmacokinetics of dexamethasone and methylprednisolone

Clinical pharmacology and therapeutics, 2003-07, Vol.74 (1), p.17-24

2003

Volltextzugriff (PDF)

Effects of aprepitant on cytochrome P450 3A4 activity using midazolam as a probe

Clinical pharmacology and therapeutics, 2003-08, Vol.74 (2), p.150-156

2003

Volltextzugriff (PDF)

Pharmacokinetics of Ertapenem in Patients With Varying Degrees of Renal Insufficiency and in Patients on Hemodialysis

Journal of clinical pharmacology, 2006-10, Vol.46 (10), p.1128-1138

2006

Volltextzugriff (PDF)

Effect of Aprepitant on the Pharmacokinetics of Intravenous Midazolam

Journal of clinical pharmacology, 2007-06, Vol.47 (6), p.744-750

2007

Volltextzugriff (PDF)

Lack of Effect of Aprepitant on Digoxin Pharmacokinetics in Healthy Subjects

Journal of clinical pharmacology, 2003-08, Vol.43 (8), p.912-917

2003

Volltextzugriff (PDF)

Pharmacokinetics of Rizatriptan Tablets During and Between Migraine Attacks

Headache, 1999-04, Vol.39 (4), p.264-269

1999

Volltextzugriff (PDF)

Pharmacokinetics and pharmacodynamics of ertapenem: an overview for clinicians: Treatment of complicated community-acquired infections with ertapenem, the first Group 1 carbapenem

Journal of antimicrobial chemotherapy, 2004, Vol.53, p.ii23-ii28

2004

Volltextzugriff (PDF)

Synthesis and characterization of monodispersed silica‐based shear thickening fluid for impact resistance applications

Polymer composites, 2024-06, Vol.45 (9), p.8469-8485

2024

Volltextzugriff (PDF)

Cytology microarray on cell block preparation: A novel diagnostic approach in fluid cytology

Journal of cytology, 2019-04, Vol.36 (2), p.79-83

2019

Volltextzugriff (PDF)

Emergence of a unique SARS‐CoV‐2 Delta sub‐cluster harboring a constellation of co‐appearing non‐Spike mutations

Journal of medical virology, 2023-01, Vol.95 (1), p.e28413-n/a

2023

Volltextzugriff (PDF)

Tolerability of Fosaprepitant and Bioequivalency to Aprepitant in Healthy Subjects

Journal of clinical pharmacology, 2007-07, Vol.47 (7), p.834-840

2007

Volltextzugriff (PDF)

Lack of effect of aprepitant on the pharmacokinetics of docetaxel in cancer patients

Cancer chemotherapy and pharmacology, 2005-06, Vol.55 (6), p.609-616

2005

Volltextzugriff (PDF)

Plant Stress: Challenges and Management in the New Decade

Volltextzugriff (PDF)

Effects of aprepitant on the pharmacokinetics of ondansetron and granisetron in healthy subjects

Clinical therapeutics, 2003-05, Vol.25 (5), p.1407-1419

2003

Volltextzugriff (PDF)

Cremophor EL-free formulation of paclitaxel: A randomized, multicenter, safety, and efficacy study of nanosomal paclitaxel lipid suspension (NPLS) versus paclitaxel in women with metastatic breast cancer (MBC)

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.573-573

2014

Volltextzugriff (PDF)

Effect of impaired renal function and haemodialysis on the pharmacokinetics of aprepitant

Clinical pharmacokinetics, 2005-01, Vol.44 (6), p.637-647

2005

Volltextzugriff (PDF)

Double-blind crossover study to assess potential differences in cytochrome P450 3A4 activity in healthy subjects receiving ondansetron plus dexamethasone, with and without aprepitant

Cancer chemotherapy and pharmacology, 2011-06, Vol.67 (6), p.1313-1321

2011

Volltextzugriff (PDF)

Pharmacokinetics of Intramuscularly Administered Ertapenem

Antimicrobial Agents and Chemotherapy, 2003-05, Vol.47 (5), p.1732-1735

2003

Volltextzugriff (PDF)

Synthesis of Furo[2,3-c]quinolin-4(5H)-ones

Heterocycles, 1999-10, Vol.51 (10), p.2399

1999

Volltextzugriff (PDF)

Pyridine hydrobromide perbromide mediated regioselective heterocyclization of ortho-cyclohexenyl phenols

Canadian journal of chemistry, 1995-10, Vol.73 (10), p.1727-1732

1995

Volltextzugriff (PDF)

1 – 25 von 33

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(26)

Publikationsform

Sprache

Englisch
(33)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Human positron emission tomography studies of brain neurokinin 1 receptor occupancy by aprepitant

Evaluation of Potential Inductive Effects of Aprepitant on Cytochrome P450 3A4 and 2C9 Activity

Pharmacokinetics of Aprepitant After Single and Multiple Oral Doses in Healthy Volunteers

Assay methodology for the quantitation of unbound ertapenem, a new carbapenem antibiotic, in human plasma

Pharmacokinetics and pharmacodynamics of ertapenem: an overview for clinicians

Effects of the neurokinin1 receptor antagonist aprepitant on the pharmacokinetics of dexamethasone and methylprednisolone

Effects of aprepitant on cytochrome P450 3A4 activity using midazolam as a probe

Pharmacokinetics of Ertapenem in Patients With Varying Degrees of Renal Insufficiency and in Patients on Hemodialysis

Effect of Aprepitant on the Pharmacokinetics of Intravenous Midazolam

Lack of Effect of Aprepitant on Digoxin Pharmacokinetics in Healthy Subjects

Pharmacokinetics of Rizatriptan Tablets During and Between Migraine Attacks

Pharmacokinetics and pharmacodynamics of ertapenem: an overview for clinicians: Treatment of complicated community-acquired infections with ertapenem, the first Group 1 carbapenem

Synthesis and characterization of monodispersed silica‐based shear thickening fluid for impact resistance applications

Cytology microarray on cell block preparation: A novel diagnostic approach in fluid cytology

Emergence of a unique SARS‐CoV‐2 Delta sub‐cluster harboring a constellation of co‐appearing non‐Spike mutations

Tolerability of Fosaprepitant and Bioequivalency to Aprepitant in Healthy Subjects

Lack of effect of aprepitant on the pharmacokinetics of docetaxel in cancer patients

Plant Stress: Challenges and Management in the New Decade

Effects of aprepitant on the pharmacokinetics of ondansetron and granisetron in healthy subjects

Cremophor EL-free formulation of paclitaxel: A randomized, multicenter, safety, and efficacy study of nanosomal paclitaxel lipid suspension (NPLS) versus paclitaxel in women with metastatic breast cancer (MBC)

Effect of impaired renal function and haemodialysis on the pharmacokinetics of aprepitant

Double-blind crossover study to assess potential differences in cytochrome P450 3A4 activity in healthy subjects receiving ondansetron plus dexamethasone, with and without aprepitant

Pharmacokinetics of Intramuscularly Administered Ertapenem

Synthesis of Furo[2,3-c]quinolin-4(5H)-ones

Pyridine hydrobromide perbromide mediated regioselective heterocyclization of ortho-cyclohexenyl phenols

Suchergebnisse filtern